DEUTSCHE BANK AG\ - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 59 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.54 and the average weighting 0.7%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$1,000
-95.2%
1,900
-90.8%
0.00%
Q1 2020$21,000
-36.4%
20,701
-5.8%
0.00%
Q4 2019$33,000
+13.8%
21,974
+33.9%
0.00%
Q3 2019$29,000
-29.3%
16,410
-35.3%
0.00%
Q2 2019$41,00025,347
+5072.9%
0.00%
Q1 2019$0
-100.0%
490
-87.7%
0.00%
Q3 2018$14,000
+100.0%
3,990
+17.4%
0.00%
Q2 2018$7,0003,4000.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders